Market Access News | pharmaphorum

News

FDA advisors have voted that the benefit/risk profile of GSK's multiple myeloma therapy, Blenrep, does not support its approval in the US.

News

Novartis' breast cancer therapy Kisqali has been cleared for NHS use in early breast cancer, an indication driving blockbuster sales of the drug.

News

AIs that detect spinal fractures during routine CT scans could help the NHS reduce hip fractures and other costly complications, says NICE.

News

The UK has unveiled its plan to revitalise the life sciences sector and become a global leader by 2030, but a pharma trade group says it falls short.

News

Federal staffers voice their anger and disgust as thousands of the Trump administration's reduction-in-force job losses are finalised.

News

The WHO has recommended Gilead's twice-yearly HIV PrEP drug lenacapavir, calling it 'transformational', but there are concerns about patient access.